Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

← @optiondt

$INCY

BULLISH2026-07-29

Price around the call

↑ 2026-07-29

By horizon✗ miss-2.6%

✗ -3.5%

✗ -7.4%

21d

✗ -2.6%

Original post

美股翻倍哥 · 2026-07-29

🔥【美股 $INCY 看涨210】 Incyte不是普通的医药股，是标普500成分股，肿瘤+血液+自免三线齐发。 ✅ Jakafi骨髓纤维化+真性红细胞增多症一线靶向，市占率超75%，现金流稳。 ✅ Opzelura白癜风几乎垄断外用处方药，Q2直接爆炸式增长。 ✅ 现金充足、管线加速账面弹药充足，持续并购补短板；新一代Oral JAK1/ALK2/BET抑制剂全力推进。综合来看，业绩超预期+现金充足+护城河深。从现在的位置到210，上涨空间巨大。上述分析仅代表个人观点，非投资建议。 #美股 $INCY #Incyte

View on X ↗